Search
Search
Joseph J. Allen, OD, FAAO, Dipl ABO
Show Description +
In this episode, Joseph J. Allen, OD, FAAO, Dipl ABO, talks about optometry’s adoption of epithelial-on corneal crosslinking, FDA-approved in late 2025. As the procedure becomes more widely commercially available, Dr. Allen stresses the importance of understanding not only how it differs from epithelial-off corneal crosslinking, but also what potential insurance hurdles may lie ahead. With ODs better-positioned to offer this noninvasive procedure, he highlights the opportunity to improve keratoconus screening efforts to better evaluate patient candidacy.
* While this video was in production, epithelial-on corneal crosslinking received a permanent J-code, J2789, effective July 1, to streamline the reporting and payment of the procedure.
Posted: 4/28/2026
Joseph J. Allen, OD, FAAO, Dipl ABO
In this episode, Joseph J. Allen, OD, FAAO, Dipl ABO, talks about optometry’s adoption of epithelial-on corneal crosslinking, FDA-approved in late 2025. As the procedure becomes more widely commercially available, Dr. Allen stresses the importance of understanding not only how it differs from epithelial-off corneal crosslinking, but also what potential insurance hurdles may lie ahead. With ODs better-positioned to offer this noninvasive procedure, he highlights the opportunity to improve keratoconus screening efforts to better evaluate patient candidacy.
* While this video was in production, epithelial-on corneal crosslinking received a permanent J-code, J2789, effective July 1, to streamline the reporting and payment of the procedure.
Posted: 4/28/2026
_1701789080.png?auto=compress,format&w=180)
.mp4.00_05_41_04.Still001_1680887186.jpg?auto=compress,format&w=180)
.00_13_09_19.Still001_1676069079.jpg?auto=compress,format&w=180)
Please log in to leave a comment.